Finance And Related Services Tenders

1413 -Jr- Mobile Radio Terminals Dbs Cat. 1

Conclusion of Non-Exclusive am Discount Agreement. According to § 130A Paragraph 8 Sgb V by Means of a So-Called Open-House Model for the Active Ingredient Tacrolimus (Atc Code According to Who: L04ad02)

Conclusion of Non-Exclusive Drug Discount Agreement. According to § 130A Paragraph 8 Sgb V by Means of a So-Called Open-House Model for the Active Ingredient Pancreatin (Atc Code According to Who: A09aa02)

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Solifenacin and Tamsulosin, Atc Code: G04ca53 for the Period from September 1St, 2023 to August 31St, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Bismuth Subcitrate, Tetracycline, Metronidazole, Atc Code: A02bd08 for the Period from September 1St, 2023 to August 31St, 2025

Completion of a Non-Excl. Discount Agreement According to § 130C Paragraph 1 Sgb V for Barictinib, Atc Code: L04aa37 for the Period from 09/01/2023 to 08/31/2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Fluorouracil, Atc Code: L01bc02 for the Period from September 1St, 2023 to August 31St, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 or § 130C Paragraph 1 Sgb V for Evinacumab, Atc Code: C10ax for the Period from September 1St, 2023 to August 31St, 2025

Completion of a Non-Excl. Discount Agreement According to § 130C Paragraph 1 Sgb V for Ribociclib, Atc Code: L01ef02 for the Period from 09/01/2023 to 08/31/2025

Oh-Biologika-2023-23 Insulin Glargine (Potency: 100 U/Ml)